PR Newswire PharmaOriginal article
WuXi Biologics Achieves MSCI ESG AAA Rating and MSCI Selection Indexes Inclusion for Fourth Consecutive Year
Positive
AI Analysis
Summary
WuXi Biologics maintained its MSCI AAA ESG Rating for the fourth consecutive year under the new ESG Model 5.0 and was included in the MSCI ESG Selection Indexes for the fourth consecutive year, positioning itself as a leader in green CRDMO solutions.
Importance:2/10
Sentiment:
0.70
ESGMSCIsustainabilityCRDMOrating
Related Companies
Read the original article
Published by PR Newswire Pharma on July 8, 2026 7:15 AM
